Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding
Clinical trial NCT07169214 · RECRUITING
Trial details
- NCT number
- NCT07169214
- Sponsor
- ScinnoHub Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-30
- Primary completion
- 2025-09-23
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.